BJMO - volume 18, issue 5, september 2024
T. Vermassen PhD, A. Decruyenaere MD, D. De Maeseneer MD, S. Rottey MD, PhD
The 2024 annual ASCO meeting offered remarkable presentations about the lastest trial updates in renal cell, bladder, testicular and prostate cancer. This article will give an overview of the key highlights in genitourinary cancers presented at ASCO 2024.
(Belg J Med Oncol 2024;18(5):206–10)
Read moreBJMO - volume 17, issue 8, december 2023
T. Vermassen PhD, A. Decruyenaere MD, D. De Maeseneer MD, S. Rottey MD, PhD
The 2023 annual ESMO meeting again offered striking presentations about the latest trial updates in genitourinary cancers, including prostate, renal cell and urothelial cell carcinomas. This article will give an overview of the key highlights presented during this meeting in this setting.
(Belg J Med Oncol 2023;17(8):313–8)
Read moreBJMO - volume 17, issue 5, september 2023
T. Vermassen PhD, A. Decruyenaere MD, D. De Maeseneer MD, S. Rottey MD, PhD
The 2023 annual ASCO meeting offered once more remarkable presentations about the last trial updates in renal cell, bladder, testicular and prostate cancer. This article will give an overview of the key highlights presented during this meeting in this setting.
(Belg J Med Oncol 2023;17(5):169–77)
Read moreBJMO - volume 16, issue 8, december 2022
A. Decruyenaere MD, S. Rottey MD, PhD, D. De Maeseneer MD, T. Vermassen PhD
The 2022 annual ESMO meeting again offered striking presentations about the last trial updates in genitourinary cancers, including prostate, renal cell and urothelial cell carcinomas. This article will give an overview of the key highlights presented during this meeting in this setting.
(Belg J Med Oncol 2022;16(8):372–9)
Read moreBJMO - volume 16, issue 5, september 2022
T. Vermassen PhD, A. Decruyenaere MD, S. Rottey MD, PhD, D. De Maeseneer MD
The 2022 ASCO Annual Meeting again offered a variety of advancements in the treatment of genitourinary cancers. In this summary, some of the highlights in the field of renal, bladder and prostate cancer will be discussed, with a particular focus on studies with a potential impact on clinical practice.
(Belg J Med Oncol 2022;16(5):214–22)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
